ReviewFoods (Basel, Switzerland)2026
Investigation of Oral Toxicity Mechanisms of Low-Molecular-Weight Polycyclic Aromatic Hydrocarbons and Probiotic Interventions Under the Framework of the "Gut-Lung Axis".
Review in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Low-molecular-weight polycyclic aromatic hydrocarbons (LMW-PAHs), as ubiquitous contaminants in the environment and food processing, have attracted growing concern due to their systemic health hazards through oral exposure. Recent studies have demonstrated that the toxic effects of LMW-PAHs extend beyond the direct damage caused by inhalation exposure. They can induce pathological changes in distal organs by disrupting the bidirectional communication system known as the "gut-lung axis". This review summarizes the major sources and health risks of LMW-PAHs and elucidates the communication mechanisms underlying the gut-lung axis, which comprises a bidirectional regulatory network involving gut microbial metabolites, circulating inflammatory factors, immune cell migration, and neuroendocrine signaling. Furthermore, the review explores the core mechanisms by which oral exposure to LMW-PAHs leads to pulmonary injury: primarily through triggering gut microbiota (GM) dysbiosis, compromising intestinal barrier integrity, and inducing intestinal inflammation, which collectively propagate lung injury via the "gut-lung axis". In response to these toxic pathways, we propose probiotic intervention strategies that may antagonize the gut-lung-axis-mediated toxicity of LMW-PAHs through multiple mechanisms, including modulation of gut microbiota composition, reinforcement of intestinal barrier integrity, systemic immune regulation, and production of beneficial metabolites such as short-chain fatty acids (SCFAs). Finally, this review discusses the application prospects and existing challenges of probiotic interventions, aiming to provide a solid theoretical foundation and novel perspective for probiotic resource development and application based on the "gut-lung axis".
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.